Alembic Pharmaceuticals Limited
http://www.alembic-india.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Alembic Pharmaceuticals Limited
ANDA Suitability Petitions: The Timelines They Are A-Changin'
US suitability petition submissions see an uptick against the backdrop of GDUFA III new goals for the FDA's response to such petitions. The Pink Sheet tracks some of the activity as applicants seek to tap market opportunities without the need for new clinical data.
Lights, Camera, Goal Dates: Pharma Gets Going With ANDA Suitability Petitions
Sponsors return with US suitability petition submissions against the backdrop of GDUFA III new goals for the FDA's response to such petitions. Scrip tracks some of the activity as applicants seek to tap market opportunities without the need for new clinical data.
ANDA Suitability Petitions: The Timelines They Are A-Changin'
US suitability petition submissions see an uptick against the backdrop of GDUFA III new goals for the FDA's response to such petitions. The Pink Sheet tracks some of the activity as applicants seek to tap market opportunities without the need for new clinical data.
US Regulatory Risks, Litigation Likely To Slow FY24 Growth For India’s Top Pharma Firms, Says ICRA
The damage at one of Pfizer’s largest injectables facilities could lead to gains for a few Indian companies, analysts feel. However, regulatory risks, litigation pay-outs and other challenges will slow growth for domestic firms and Indian units of multinationals like Abbott and Pfizer in FY24, says rating agency ICRA as Q1 results begin coming in
Company Information
- Industry
-
Services
- Hospitals, Nursing Homes, Institutions
-
Pharmaceuticals
- Generic Drugs
- Other Names / Subsidiaries
-
- Orit Laboratories Alembic Global Holding SA Aleor Dermaceuticals Limited Alembic Pharmaceuticals Australia Pty Limited Alembic Pharmaceuticals Europe Limited Alembic Pharmaceuticals Inc Alembic Pharmacueticals Canada Limited Alnova Pharmaceuticals SA Genius LLC
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice